Swaza is a clinical-stage biotechnology company developing advanced drug delivery systems and regenerative biomaterials for respiratory failure, wound and burn healing, human performance and longevity. The company’s lead program, SWAZA-1, is a first-in-class nanofluid breathing aid designed to improve gas exchange without oxygen tanks or ventilators. Swaza was selected from more than 2,600 companies worldwide by NATO DIANA to advance biotechnology and human-resilience innovations for allied defense. The company has contracts with BARDA, NASA, and NATO, and is a Johnson & Johnson Innovation Blue Knight company. Swaza is preparing to launch a $12 million Series A financing to advance SWAZA-1 clinical development to Phase 2a and advance its programs for novel GLP1RA delivery and regenerative materials.

Muse Bio is a regenerative biotech company creating ingredients, products, and therapeutics from menstrual blood–derived stem cell secretome. Its platform uniquely targets the fibrotic cascade — the scarring and tissue hardening that underlies disease, injury, and aging, and is associated with roughly 45% of U.S. mortality. The company's strategy is sequential commercialization: an aesthetics ingredient wedge generating revenue today (priced at $30/ml with a 40% profit-share) that simultaneously de-risks the preclinical package, expanding into fertility/IVF as the lead clinical indication and then broader fibrotic disease and regenerative medicine. Muse commercialized its first product in under four months — versus five years for the incumbent — and now reaches thousands of clinics through B2B distributors at near-zero customer acquisition cost, with 300% recent customer growth and enterprise buyers in the pipeline.

Biomanufacturing still runs on WWII-era steel tanks: slow, billion-dollar infrastructure that's been quietly offshored. We are replacing it with living factories. At Buzz Biolabs we have undertaken a species engineering effort to turn nature's most efficient protein producer - the Black Soldier Fly—into a Biological factory. As next-generation therapies for longevity and disease shift toward peptides and complex biologics, manufacturing becomes the critical bottleneck. Our platform is built to meet that demand at scale in the United States.

Yuvan Research Inc. is a biotechnology company built around a proprietary extracellular vesicle (EV) platform for delivering therapeutic cargo — small molecules, siRNA, and other payloads — using the body's own vesicle biology rather than synthetic carriers. This presentation focuses on Yuvan's EV-delivered siRNA combination therapy for TP53-mutant acute myeloid leukemia (AML), a treatment-refractory patient population with no approved targeted therapies and poor response to standard-of-care venetoclax/hypomethylating-agent regimens. The therapy targets two independent AML vulnerabilities — YUV1 and YUV2 — and in preclinical testing, EV-delivered siRNA achieved 45–51% target knockdown, with a 4–5-fold apoptotic selectivity window over non-malignant control cells.

Diamond Quanta is commercializing the Adamantine PlatformTM, a manufacturable interface engineering platform that enables the scalable deployment of engineered diamond across semiconductor devices and advanced materials applications. By combining proprietary diamond deposition, defect engineering, and post-process densification, the company is addressing long-standing barriers to commercial adoption across semiconductor manufacturing ecosystems through a capital-efficient, licensing-driven commercialization strategy.

DeepShare is building Javis (HiJavis), an owner-centric personal AI platform that gives every user their own cloud-hosted AI agent and turns everyday voice and text into a searchable, actionable "second brain"—no server or technical setup required. With one-tap recording from earbuds or a smartphone, plus a custom keyboard, Javis captures meetings, conversations, and ideas. Installable AI skills automatically transcribe, summarize, extract action items, generate agendas, and create calendar events.

Mavlipa is developing an advanced system used for real-time monitoring and detection of particle sizes in CMP (Chemical Mechanical Planarization) slurries.

Beshton Software is proud to help businesses thrive with tailored enterprise software solutions. Based in Silicon Valley, we provide comprehensive IT services to fit your unique needs.

Superbio.ai is the world’s first AI store for biology.